Abstract

Xanthohumol (XH) is an important prenylated flavonoid that is found within the inflorescence of Humulus lupulus L. (Hop plant). XH is an important ingredient in beer and is considered a significant bioactive agent due to its diverse medicinal applications, which include anti-inflammatory, antimicrobial, antioxidant, immunomodulatory, antiviral, antifungal, antigenotoxic, antiangiogenic, and antimalarial effects as well as strong anticancer activity towards various types of cancer cells. XH acts as a wide ranging chemopreventive and anticancer agent, and its isomer, 8-prenylnaringenin, is a phytoestrogen with strong estrogenic activity. The present review focuses on the bioactivity of XH on various types of cancers and its pharmacokinetics. In this paper, we first highlight, in brief, the history and use of hops and then the chemistry and structure–activity relationship of XH. Lastly, we focus on its prominent effects and mechanisms of action on various cancers and its possible use in cancer prevention and treatment. Considering the limited number of available reviews on this subject, our goal is to provide a complete and detailed understanding of the anticancer effects of XH against different cancers.

Highlights

  • Tremendous interest has emerged toward bioactive natural compounds owing to their pharmacological activities in various chronic diseases, such as neoplasms, neurological diseases, viral and bacterial infections, and many more

  • Chemo- and radiosensitizing experiments on MCF-7/ADR cells revealed that XH was able to attenuate MCF-7/ADR cell sensitivity to adriamycin therapies and radiation that inhibited the expression of epidermal growth factor receptor (EGFR), signal transducer and activator of transcription 3 (STAT3), and multidrug resistance mutation 1 (MDR1), known as ATP binding cassette subfamily B member 1 (ABCB1)

  • This review summarized recent progress on XH, that inhibits carcinogenesis and metastasis in many cancers

Read more

Summary

Introduction

Tremendous interest has emerged toward bioactive natural compounds owing to their pharmacological activities in various chronic diseases, such as neoplasms, neurological diseases, viral and bacterial infections, and many more. Among different naturally-occurring compounds, hops, which are obtained from the inflorescence (female) of Humulus lupulus L. XH is written as 3 -[3, 3-dimethyl allyl]-2 ,4 ,4-trihydroxy-6 -methoxychalcone [11] The prenylated flavonoids, such as isoxanthohumol, 6-prenylnaringenin, and 8prenylnaringenin (8-PN), are isomers of XH, which have potent anti-inflammatory, antineoplastic, antidiabetic, estrogenic, antiviral, and antibacterial activities [12]. There is limited information available about the bioavailability and bioactivity of XH in humans, but preclinical studies on XH suggests that it has a cancer-preventive effect. In 1935, a voyage of archaeologists from the Pennsylvania University Museum and the American Schools of Oriental Science in Mesopotamia discovered a seal baked into pottery that depicted the contents of a brewery vat which was stirred with long poles by two brewery workers This instance was dated back to 3500–3100 BC [13]. Hops alcohol extracts have been utilized in Chinese medicine for pulmonary tuberculosis and acute bacterial dysentery treatment as well as in Ayurvedic therapies in India [28]

Hop Botany
Hop Cultivation
XH and Brewing
Chemistry and SAR of XH
Anticancer Potential of XH Based on Preclinical Evidence
Breast Cancer
Cervical Cancer
Cholangiocarcinoma
Colon Cancer
Esophageal Cancer
Glioblastoma
Hematological Cancers
Laryngeal Cancer
Liver Cancer
4.10. Lung Cancer
4.11. Melanoma
4.12. Oral Cancer
4.13. Ovarian Cancer
4.14. Pancreatic Cancer
4.15. Prostate Cancer
4.16. Thyroid Cancer
Biotransformation and Pharmacokinetics of XH
Findings
Conclusions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call